California is contracting with Amneal Pharmaceuticals, which last week secured federal approval for its over-the-counter naloxone nasal spray, a generic version of the brand-name drug Narcan.

California can buy more overdose-reversing medication at a lower price under a deal Gov. Gavin Newsom’s office announced Monday with a pharmaceutical company, potentially giving law enforcement ...

BRIDGEWATER, N.J., November 21, 2024--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, today ...

Amneal announced the advancement of two key strategic initiatives. Amneal has received approval from the Food and Drug Administration for exenatide, which is the company’s first generic ...

Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts Amneal Pharmaceuticals Q3 sales rose 13% to $702.47 million, beating estimates. EPS hit $0.16, above consensus, driven ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key ...

On Friday, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) reported third-quarter adjusted EPS of $0.16, down from $0.19 a year ago, beating the consensus of $0.14. The company reported sales of $702.47 ...

BRIDGEWATER, N.J. — BRIDGEWATER, N.J. — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported a third-quarter loss of $156,000, after reporting a profit in the same period a year earlier.

A live webcast will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event. Amneal Pharmaceuticals, Inc. (Nasdaq ...